Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:55 PM
Ignite Modification Date:
2025-12-24 @ 9:55 PM
NCT ID:
NCT06983132
Eligibility Criteria:
Inclusion Criteria:
* Patients with familial cerebral cavernous malformations (FCCM), documented by mutations in the CCM1, CCM2, or CCM3 genes;
* Asymptomatic patients or those with a history of clinical symptoms or events, such as intracerebral hemorrhage, stroke, permanent or transient focal deficits, seizures, disability, or any other neurological symptom presumably related to CCM;
* Life expectancy at least equal to the duration of the study follow-up;
* Written informed consent from the patient (or guardian in the case of minors) to participate in the study.
Exclusion Criteria:
* Implanted pacemaker or any other condition that precludes magnetic resonance imaging;
* Participation in another ongoing interventional clinical study;
* Inability to cooperate with the study procedures.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT06983132
Study Brief:
Protocol Section:
NCT06983132